TITLE

Prednisolone plus a disease-modifying antirheumatic drug improved outcomes in early rheumatoid arthritis: COMMENTARY

AUTHOR(S)
Schattner, Ami
PUB. DATE
May 2006
SOURCE
ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p73
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents the author's views regarding a study on the effect of prednisolone and modifying antirheumatic drug in early rheumatoid arthritis (RA). Prevention of irreversible joint damage, functional decline, and reduced survival is the main goal in the treatment of RA. In the study a meticulous assessment of 250 randomized patients was conducted, which strongly indicated that low-dose prednisolone is a very beneficial adjunctive treatment in patients with early RA. The author insists that a more intensive antiosteoporotic treatment is warranted.
ACCESSION #
21490798

 

Related Articles

  • Stress und Rheuma. Malysheva, O.; Pierer, M.; Wagner, U.; Baerwald, C.G.O. // Zeitschrift für Rheumatologie;Aug2010, Vol. 69 Issue 6, p539 

    Rheumatoid arthritis (RA) is a chronic rheumatic disease of unknown aetiology and variable severity. It is now well known that several risk factors are involved in its pathogenesis, including genetic factors and sex hormones as well as environmental factors, i.e. infections and stress. In...

  • MANAGEMENT OF CARDIOVASCULAR RISK FACTORS IN PATIENTS W ITH SYSTEMIC LUPUS ERYTHEMATOSUS. Rahman, Anisur // Acta Reumatológica Portuguesa;2008, Vol. 33 Issue 1, p13 

    The article discusses management cardiovascular risk factors in patients with systematic lupus erythematosus (SLE). It mentions that cardiovascular disease such as coronary artery disease and strokes are causes of death in patients with SLE compared to age and sex-matched controls. Rheumatoid...

  • Rheumatoid Arthritis Trial. Hampton, Tracy // JAMA: Journal of the American Medical Association;9/22/2004, Vol. 292 Issue 12, p1419 

    Reports on the launch of a new study to determine how individuals with rheumatoid arthritis evaluate improvements in disease symptoms during treatment. Need for the trial; Plans for people to be recruited for the study.

  • A clinical prediction guide predicted progression to rheumatoid arthritis in undifferentiated arthritis.  // Evidence Based Medicine;Oct2007, Vol. 12 Issue 5, p154 

    The article presents the author's view on the study "A prediction rule for the disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions." He contends that the authors have taken a step further to diagnose early rheumatoid arthritis...

  • Abatacept: the evidence for its place in the treatment of rheumatoid arthritis. Köller, Marcus D. // Core Evidence;2007, Vol. 2 Issue 3, p163 

    Introduction: Rheumatoid arthritis (RA) is the most common inflammatory joint disease in adults with a prevalence of 0.5-1%. The development of targeted therapies, especially anti-TNF (tumor necrosis factor) treatment, has improved disease outcome during the last decade. But despite this...

  • Initial combination therapy with prednisone or infliximab improved outcomes in early rheumatoid arthritis more than DMARDs alone.  // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p72 

    The article presents information on a study on the clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (RA). The study included 508 patients with a history of no previous treatment with a disease-modifying antirheumatic drug...

  • Initial combination therapy with prednisone or infliximab improved outcomes in early rheumatoid arthritis more than DMARDs alone: COMMENTARY. York, Michael; Hunter, David J. // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p72 

    The article presents the author's views regarding a study on the clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (RA). Aggressive treatment of early RA has been shown to limit functional disability and radiographic...

  • COMMENTARY: Review: Anti-tumor necrosis factor antibody therapy for rheumatoid arthritis increases risk for serious infection and malignancy. Shoor, Stanford // ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p65 

    The article presents the author's comments on a medical study on anti-tumor necrosis factor (anti-TNF) antibody therapy for rheumatoid arthritis. The study revealed that the antibody therapy for rheumatoid arthritis increases risk for serious infection and malignancy. But the author says that...

  • Can breastfeeding prevent RA? Tanday, Sanjay // GP: General Practitioner;5/23/2008, p16 

    The article reports on a study which suggests that women who breasted for more that a year lessen their risk of developing rheumatoid arthritis (RA). It relates that the study compared 136 women aged 44-74 who developed RA between 1991 and 1996 with control group of 544 healthy women. The result...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics